Literature DB >> 11878310

Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues.

R de Kanter1, M Monshouwer, D K F Meijer, G M M Groothuis.   

Abstract

Metabolism of xenobiotics is often seen as an exclusive function of the liver, but some current findings support the notion that the lungs, kidneys and intestine may contribute considerably. After the establishment of the use of liver slices as a useful in vitro model to study metabolism and toxicity of xenobiotics, the same concept is currently being used for slices from lung, kidney and intestine. It is the aim of this review to discuss the use of organ slices in biotransformation research. The basic idea behind the use of tissue slices in biomedical research is the assumption that the cells under study will function optimally in vitro if they are cultivated in an environment that is most alike to their natural in vivo embedding, which is the case in tissue slices. Advantages in the use of organ slices are the relatively easy preparation as well as the potential standardization of both the preparation and use. Moreover, a direct interspecies comparison can be made between liver, lungs, kidneys and intestines, for example with respect to their metabolic capacity and their sensitivity for toxicants. Of major importance is that organ slices can be made with a similar procedure from organs/tissues originating from different species, including man. This latter aspect is useful in drug development in general but also for a better insight in the metabolic fate of compounds in man. Importantly the use of slices may largely contribute to a reduction in the use of experimental animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878310     DOI: 10.2174/1389200023338071

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  21 in total

Review 1.  In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Authors:  Sandrine A L Audouy; Lou F M H de Leij; Dick Hoekstra; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Precision-cut slice culture method for rat placenta.

Authors:  J Gilligan; M Tong; L Longato; S M de la Monte; F Gundogan
Journal:  Placenta       Date:  2011-11-12       Impact factor: 3.481

3.  Interspecies considerations in the evaluation of human food safety for veterinary drugs.

Authors:  Arthur L Craigmill; Kristy A Cortright
Journal:  AAPS PharmSci       Date:  2002

4.  Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

Authors:  Inge A M de Graaf; Peter Olinga; Marina H de Jager; Marjolijn T Merema; Ruben de Kanter; Esther G van de Kerkhof; Geny M M Groothuis
Journal:  Nat Protoc       Date:  2010-08-19       Impact factor: 13.491

Review 5.  Organ-on-a-chip for assessing environmental toxicants.

Authors:  Soohee Cho; Jeong-Yeol Yoon
Journal:  Curr Opin Biotechnol       Date:  2017-01-11       Impact factor: 9.740

6.  Targeting tumors using nanoparticle platforms: a phase I study of a systemically administered gene therapy system.

Authors:  Christopher Larson; Natalie Mendez; Tony Reid
Journal:  Mol Ther       Date:  2013-05       Impact factor: 11.454

7.  A microfluidic platform for functional testing of cancer drugs on intact tumor slices.

Authors:  A D Rodriguez; L F Horowitz; K Castro; H Kenerson; N Bhattacharjee; G Gandhe; A Raman; R J Monnat; R Yeung; R C Rostomily; A Folch
Journal:  Lab Chip       Date:  2020-04-09       Impact factor: 6.799

8.  Screening for Chemical Toxicity Using Cryopreserved Precision Cut Lung Slices.

Authors:  Christa Y Watson; Flavia Damiani; Sumati Ram-Mohan; Sylvia Rodrigues; Priscila de Moura Queiroz; Thomas C Donaghey; Jamie H Rosenblum Lichtenstein; Joseph D Brain; Ramaswamy Krishnan; Ramon M Molina
Journal:  Toxicol Sci       Date:  2015-12-29       Impact factor: 4.849

9.  Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices.

Authors:  Michael-A van Geer; Koert F D Kuhlmann; Conny T Bakker; Fibo J W ten Kate; Ronald P J Oude Elferink; Piter J Bosma
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

10.  Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1.

Authors:  M Kasper; D Seidel; L Knels; N Morishima; A Neisser; S Bramke; R Koslowski
Journal:  Histochem Cell Biol       Date:  2004-01-30       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.